CJC-1295 DAC 5 mg / 10 mg
CJC-1295 DAC is a long-acting synthetic analog of Growth Hormone-Releasing Hormone (GHRH) developed for laboratory research involving endocrine physiology, peptide signaling, and metabolic regulation. Engineered with Drug Affinity Complex (DAC) technology, CJC-1295 DAC has become one of the most extensively investigated peptides in endocrine and growth hormone research because of its prolonged biological activity and sustained receptor interaction.
Researchers continue to investigate CJC-1295 DAC for its influence on growth hormone signaling, insulin-like growth factor (IGF-1) regulation, metabolic physiology, and cellular communication. Its innovative molecular design and continued scientific interest have established CJC-1295 DAC as a valuable research tool across numerous areas of peptide science.
At Axiom Prime Labs, every vial of CJC-1295 DAC is manufactured under rigorous quality standards to provide researchers with premium laboratory-grade materials engineered for exceptional purity, consistency, and scientific investigation.
Scientific Background
CJC-1295 DAC is a synthetic peptide designed to mimic the biological activity of endogenous Growth Hormone-Releasing Hormone (GHRH), the naturally occurring hormone responsible for stimulating growth hormone secretion from the anterior pituitary gland. Unlike native GHRH, CJC-1295 incorporates Drug Affinity Complex (DAC) technology, allowing reversible binding to circulating albumin and significantly extending its biological half-life in laboratory models.
Since its development, CJC-1295 DAC has become a prominent research peptide for studies involving endocrine regulation, peptide pharmacology, metabolic physiology, and growth hormone signaling. Its prolonged activity has made it especially valuable for researchers investigating sustained receptor activation and long-term endocrine responses.
Mechanism of Action
Current research suggests that CJC-1295 DAC may influence several interconnected biological pathways involved in endocrine signaling and metabolic regulation. Investigators continue to study its interaction with:
- Growth Hormone-Releasing Hormone (GHRH) receptors
- Growth hormone signaling pathways
- Insulin-like Growth Factor-1 (IGF-1) regulation
- Endocrine feedback mechanisms
- Cellular metabolism
- Protein synthesis pathways
- Energy metabolism
- Cellular communication
These molecular interactions remain active areas of scientific investigation. Much of the current understanding is based on laboratory and preclinical research, while ongoing studies continue to expand knowledge of CJC-1295 DAC’s biological functions.
Current Areas of Research
Scientific interest in CJC-1295 DAC spans multiple disciplines of endocrine physiology and peptide science. Current laboratory research has explored its role in:
- Growth hormone physiology
- Endocrine signaling
- IGF-1 regulation
- Protein metabolism
- Metabolic research
- Exercise physiology
- Healthy aging biology
- Recovery physiology
- Cellular metabolism
- Peptide pharmacology
These areas remain the focus of ongoing scientific investigation designed to improve understanding of hormone regulation, metabolic physiology, and endocrine biology.
Research Highlights
✔ Premium Laboratory-Grade Peptide
✔ Long-Acting GHRH Analog with DAC Technology
✔ High-Purity Lyophilized Formula
✔ Manufactured Under Rigorous Quality Standards
✔ Verified Identity and Purity Testing
✔ Exceptional Batch-to-Batch Consistency
✔ Precision Engineered for Scientific Research
✔ Secure Laboratory Packaging
✔ Intended for Qualified Research Professionals
Why Researchers Choose CJC-1295 DAC
CJC-1295 DAC has become one of the most extensively studied peptides in endocrine research because of its extended biological activity and sustained interaction with Growth Hormone-Releasing Hormone receptors. Its innovative Drug Affinity Complex technology has established CJC-1295 DAC as an important research tool for investigators studying hormone regulation, peptide pharmacology, metabolic physiology, and endocrine signaling.
Researchers value CJC-1295 DAC for its unique molecular design and continued relevance across multiple fields of peptide and endocrine research.
The Axiom Prime Labs Quality Commitment
Quality Without Compromise
At Axiom Prime Labs, quality is engineered into every stage of our manufacturing process. Every research peptide is produced under carefully controlled standards and undergoes rigorous identity and purity verification to help ensure exceptional consistency and reliability.
We are committed to providing researchers with premium laboratory-grade materials that support scientific excellence through precision, transparency, and uncompromising quality.
Research FAQs
What is CJC-1295 DAC?
CJC-1295 DAC is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) engineered with Drug Affinity Complex technology to provide prolonged biological activity for laboratory research.
Why is CJC-1295 DAC widely researched?
Researchers continue to investigate CJC-1295 DAC because of its interaction with endocrine signaling pathways involved in growth hormone regulation, IGF-1 physiology, metabolic biology, and peptide pharmacology.
What does DAC technology do?
Drug Affinity Complex (DAC) technology allows reversible binding to serum albumin, extending the peptide’s biological activity and making it valuable for studies involving sustained endocrine signaling.
Why is peptide purity important?
High-purity research peptides help promote experimental consistency by reducing impurities that could influence laboratory outcomes. Maintaining strict quality standards is essential for producing dependable research materials.
